glp 1 tri New weight loss drug dubbed 'triple G' shows promise: What to know about retatrutide 1 production. The Road towards Triple Agonists:

KPV manages inflammatory cascades that could otherwise impair healing

Model predicts most lost weight returns within one year The authors retrieved 48 relevant studies involving overweight or obese participants

There is some, and anecdotally, Ive definitely seen some patients get good results

3- Other observational/registry studies (e.g., in Denmark and Norway) reported similar findings: for example, in a Danish cohort of over 400,000 Type 2 diabetics, the relative risk of NAION with semaglutide was reported ~2.19-2.81 times that of non-users, though the absolute annual risk remained low

Ignore the macro and buy great companies or let the big picture drive everything